The Oxalosis & Hyperoxaluria Foundation (EIN 911457505) - Form 990 Financial Analysis & Trantor Score

🔒

Financial Vulnerability Assessment (Tuckman-Chang)

4 risk indicators measuring financial stability and operational resilience

Sign in with your work email to view Tuckman-Chang indicators

Financial Trends

Organization Details

Formation Year

2001

Legal Domicile

Principal Officer

Kim Hollander

Phone

2127770470

Tax Period

2024-01-01 to 2024-12-31

The Oxalosis & Hyperoxaluria Foundation, founded in 2001, is a community nonprofit in the Diseases & Disorders sector that reported $1.6M in total revenue in fiscal year 2024. Revenue surged 21% from the prior year, signaling strong growth momentum. The organization ran a surplus of $256K, a strong 17% operating margin.

Mission

The Oxalosis & Hyperoxaluria Foundation (OHF) is dedicated to finding treatments and a cure for all forms of hyperoxaluria.

🔒

Trantor Score

Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency

Sign in to view Trantor Score and financial metrics

Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)

Financial Overview (2024)

Revenue Breakdown

Contributions & Grants $749,795

Program Service Revenue $299,450

Investment Income $503,552

Other Revenue $0

TOTAL REVENUE $1,552,797

Expense Breakdown

Grants Paid $632,009

Salaries & Benefits $367,047

Fundraising Expenses $13,646

Program Expenses $1,166,724

Other Expenses $297,274

TOTAL EXPENSES $1,296,330

Year-over-Year Comparison

	2024	2023	Change
Revenue	$1,552,797	$1,285,664	+0.2%
Expenses	$1,296,330	$706,363	+0.8%
Net Income	$256,467	$579,301	-0.6%

Key Indicators

✓ Grants to Organizations ✓ Grants to Individuals ✗ Lobbying ✗ Political Activity ✓ Foreign Activities ✗ Donor Advised Fund ✓ Schedule B Required

🔒

Financial Health Indicators

Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics

Financial Distress Indicator

Liquidity & Cash Position

Sign in to view all financial metrics

Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics

Governance

Voting Members

Independent Members

Employees

Volunteers

Governance Policies

✓ Conflict of Interest Policy

✓ Whistleblower Policy

✓ Document Retention Policy

Special Practices & Reported Activities

✗ Operated a School

✗ Operated a Hospital

✗ Provided First Class Travel

⚠ Reported Conflict of Interest

✗ Reported Asset Diversion

✗ Excess Benefit Transaction

✗ Made Political Expenditures

✗ Engaged in Lobbying

✗ Operated Donor Advised Fund

✗ Maintained Art Collections

✗ Filed Form 720

Compensation of Officers, Directors & Key Employees

Total Officers

Total Directors

Key Employees

$253,394

Highest Compensated

reported

Name	Title	Hours/Week	Role	Reportable Comp	Other Comp	Total
William Tidmore	President	5.00	Officer Director	$0	$0	$0
Tim Berra	Vice-President	5.00	Officer Director	$0	$0	$0
Brett Rosen	Chair/Treasurer	5.00	Officer Director	$0	$0	$0
Art McGill	Director	5.00	Director	$0	$0	$0
Brendan McGovern	Director	5.00	Director	$0	$0	$0
Debbie Wattenberg	Director	5.00	Director	$0	$0	$0
Kim Hollander	Executive Director	40.00	Key Emp	$231,000	$22,394	$253,394

Note: Compensation data is self-reported by the organization on their Form 990. "Reportable Comp" includes salary, bonuses, and other reportable compensation from the organization and related organizations. "Other Comp" includes benefits, deferred compensation, and non-taxable benefits.

Historical Data

Year	Revenue	Expenses	Assets	Net Income
2024	$1,552,797	$1,296,330	$6,858,963	$256,467
2023	$1,285,664	$706,363	$6,411,517	$579,301
2022	$936,432	$640,998	$5,524,708	$295,434
2021	$1,693,241	$843,219	$5,688,162	$850,022
2020	$1,909,479	$979,022	$5,246,686	$930,457
2019	$1,490,928	$1,451,184	$4,499,799	$39,744
2018	$1,201,583	$891,187	$3,749,766	$310,396

The Oxalosis & Hyperoxaluria Foundation